Human T-Lymphotropic Virus (HTLV) Types I/II Antibodies by ELISA with Reflex to HTLV-I/II Confirmation by Western Blot
Also known as: HTLV PAN
Use
This test is intended for the qualitative detection of antibodies to Human T-Lymphotropic Virus (HTLV) Types I and II in serum or plasma. It is used to assist in the diagnosis of HTLV infection, which may be linked to adult T-cell leukemia/lymphoma and HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). The ELISA screen is a sensitive assay that initially detects the antibodies, and if the result is repeatedly reactive, a more specific confirmation by Western Blot is performed to confirm the presence of antibodies to HTLV-I/II.
Special Instructions
Not provided.
Limitations
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P). The test is not cleared or approved by the FDA and is performed in a CLIA certified laboratory. False positives or false negatives may occur due to cross-reactivity with other proteins or substances in the sample.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 29901-6 - HTLV I+II Ab Ser Ql IA
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.5 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells as soon as possible or within 2 hours of collection.
Storage Instructions
Refrigerated. Ambient is unacceptable; frozen is indefinitely stable.
Causes for Rejection
Specimens containing particulate material.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 1 week |
| Frozen | Indefinitely |
Other tests from different labs that may be relevant
